Postdoc: Targeted Protein Degradation in Cancer Drug Discovery in Dundee

Postdoc: Targeted Protein Degradation in Cancer Drug Discovery in Dundee

Dundee Full-Time 42750 - 52250 £ / year (est.) No working from home possible
R

At a Glance

  • Tasks: Join a cutting-edge team to develop molecular glue degraders for cancer research.
  • Company: The University of Dundee, a leader in innovative cancer drug discovery.
  • Benefits: Gain valuable research experience and contribute to impactful cancer therapeutics.
  • Other info: Collaborative environment with opportunities for professional growth and networking.
  • Why this job: Make a real difference in cancer treatment while advancing your scientific career.
  • Qualifications: PhD in relevant field and strong research skills in molecular biology.

The predicted salary is between 42750 - 52250 £ per year.

The University of Dundee's Ce TPD invites applications for a Postdoctoral Research Assistant to join the ACBI-glue team, focusing on developing molecular glue degraders for cancer targets.

You'll identify ubiquitin E3 ligases, validate interactions in cellular and in vitro systems, and apply high-throughput screening to discover small molecules that act as molecular glues, contributing to translational cancer therapeutics.

#J-18808-Ljbffr

Postdoc: Targeted Protein Degradation in Cancer Drug Discovery in Dundee employer: RFCSR

At King’s College London, we pride ourselves on being an exceptional employer that fosters a collaborative and innovative work culture. Our interdisciplinary approach not only encourages professional growth through diverse research opportunities but also allows you to make a meaningful impact in the fields of engineering and biomedical research. Located in the vibrant city of London, our institution offers a dynamic environment where creativity thrives and employees are supported in their career development.

R

Contact Details:

RFCSR Recruitment Team

We think you need these skills to ace Postdoc: Targeted Protein Degradation in Cancer Drug Discovery in Dundee

Molecular Biology
Cellular Systems Validation
In Vitro Techniques
High-Throughput Screening
Ubiquitin E3 Ligases Identification
Small Molecule Discovery
Translational Cancer Therapeutics